NCT07746544 — "Study of Secutrelvir in Participants With COVID-19" trial site landscape

Public-registry site landscape for NCT07746544, “Study of Secutrelvir in Participants With COVID-19”, a COVID-19 study sponsored by Shionogi. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07746544 (registry record)
Study title	Study of Secutrelvir in Participants With COVID-19
Official title	A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Secutrelvir in Participants With COVID-19
Sponsor	Shionogi
Condition(s)	COVID-19
Phase	PHASE3
Listed sites	1
Site countries	Japan

Patient-friendly overview of this study: eichor.com/study/NCT07746544.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07746544 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →